Research Topics

Nils Griebenow

Summary

Affiliation: Bayer HealthCare AG
Country: Germany

Publications

  1. ncbi Identification and optimization of substituted 5-aminopyrazoles as potent and selective adenosine A1 receptor antagonists
    Nils Griebenow
    Bayer Schering Pharma AG, Global Drug Discovery, Medicinal Chemistry Wuppertal, Building 460, D 42096 Wuppertal, Germany
    Bioorg Med Chem Lett 20:5891-4. 2010

Detail Information

Publications1

  1. ncbi Identification and optimization of substituted 5-aminopyrazoles as potent and selective adenosine A1 receptor antagonists
    Nils Griebenow
    Bayer Schering Pharma AG, Global Drug Discovery, Medicinal Chemistry Wuppertal, Building 460, D 42096 Wuppertal, Germany
    Bioorg Med Chem Lett 20:5891-4. 2010
    ..Potent and selective adenosine A(1) receptor antagonists were disclosed. SAR and pharmacological profile of selected compounds were discussed...